A.R.T. Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-23,900
Closed -$1.25M 1573
2017
Q4
$1.25M Buy
+23,900
New +$1.28M 0.06% 542
2017
Q3
Sell
-15,400
Closed -$544K 1425
2017
Q2
$544K Sell
15,400
-77,600
-83% -$2.4M 0.03% 768
2017
Q1
$2.2M Sell
93,000
-47,100
-34% -$933K 0.1% 285
2016
Q4
$1.87M Buy
140,100
+125,800
+880% +$2.03M 0.11% 289
2016
Q3
$265K Buy
+14,300
New +$252K 0.09% 390
2016
Q1
Sell
-383,869
Closed -$3.54M 1449
2015
Q4
$3.54M Buy
+383,869
New +$3.57M 0.17% 144
2014
Q4
Sell
-63,269
Closed -$1.23M 1479
2014
Q3
$1.23M Buy
+63,269
New +$1.16M 0.06% 442
2014
Q1
Sell
-40,241
Closed -$472K 1390
2013
Q4
$472K Sell
40,241
-103,959
-72% -$1.19M 0.03% 788
2013
Q3
$1.7M Buy
+144,200
New +$1.85M 0.09% 317

Other funds holding EXAS

A.R.T. Advisors's EXAS Position: Q1 2018 in Review

A.R.T. Advisors sold out of Exact Sciences (EXAS) in Q1 2018, closing a stake of 23,900 shares — an estimated $1.25M sold.

A.R.T. Advisors first reported a position in EXAS in Q3 2013 and held it in 9 quarters. The position peaked at $3.54M in Q4 2015. 319 funds tracked by Wall St. Rank hold EXAS as of Q1 2018.

  • A.R.T. Advisors reported no remaining Exact Sciences position as of Q1 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 23,900 Exact Sciences shares in Q1 2018, an estimated $1.25M.
  • A.R.T. Advisors first reported a position in Exact Sciences in Q3 2013 and held it in 9 quarters.
  • A.R.T. Advisors's Exact Sciences position peaked at $3.54M in Q4 2015.
  • 319 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2018.

Based on A.R.T. Advisors's 13F filing for Q1 2018, filed 15 May 2018.